4831 - 4840 of 8654 Results
Title
Year
- Deletion of adenosine A1 or A2A receptors reduces l-3,4-dihydroxyphenylalanine-induced dyskinesia in a model of Parkinson's disease2010OPENTitle: Deletion of adenosine A1 or A2A receptors reduces l-3,4-dihydroxyphenylalanine-induced dyskinesia in a model of Parkinson's diseaseJournal Name: Brain ResearchPublisher: Elsevier BVVol: 1367Issue #:Start Page: 310End Page: 318Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.brainres.2010.08.099Citation Count: 48
- Allopurinol reduces levels of urate and dopamine but not dopaminergic neurons in a dual pesticide model of Parkinson׳s disease2014OPENTitle: Allopurinol reduces levels of urate and dopamine but not dopaminergic neurons in a dual pesticide model of Parkinson׳s diseaseJournal Name: Brain ResearchPublisher: Elsevier BVVol: 1563Issue #:Start Page: 103End Page: 109Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.brainres.2014.03.031Best OA location URL: https://europepmc.org/articles/pmc4146456?pdf=renderCitation Count: 17
- Hypermethylation of Synphilin-1, Alpha-Synuclein-Interacting Protein (SNCAIP) Gene in the Cerebral Cortex of Patients with Sporadic Parkinson’s Disease2017OPENTitle: Hypermethylation of Synphilin-1, Alpha-Synuclein-Interacting Protein (SNCAIP) Gene in the Cerebral Cortex of Patients with Sporadic Parkinson’s DiseaseJournal Name: Brain SciencesPublisher: MDPI AGVol: 7Issue #: 7Start Page: 74End Page: 74Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/brainsci7070074Best OA location URL: https://www.mdpi.com/2076-3425/7/7/74/pdf?version=1500945204Citation Count: 20
- Why Do We Need Multifunctional Neuroprotective and Neurorestorative Drugs for Parkinson’s and Alzheimer’s Disorders?2010OPENTitle: Why Do We Need Multifunctional Neuroprotective and Neurorestorative Drugs for Parkinson’s and Alzheimer’s Disorders?Journal Name: Rambam Maimonides Medical JournalPublisher: Rambam Health CorporationVol: 1Issue #: 2Start Page: e0011End Page: e0011Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.5041/rmmj.10011Best OA location URL: https://www.rmmj.org.il/userimages/13/0/PublishFiles/13Article.pdfCitation Count: 8
- Multiplex immunoassay characterization and species comparison of inflammation in acute and non-acute ischemic infarcts in human and mouse brain tissue2016OPENTitle: Multiplex immunoassay characterization and species comparison of inflammation in acute and non-acute ischemic infarcts in human and mouse brain tissueJournal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 4Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40478-016-0371-yBest OA location URL: https://actaneurocomms.biomedcentral.com/track/pdf/10.1186/s40478-016-0371-yCitation Count: 67
-
OPENTitle: Genome-wide pleiotropy analysis of neuropathological traits related to Alzheimer’s diseaseJournal Name: Alzheimer's Research & TherapyPublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13195-018-0349-zBest OA location URL: https://doi.org/10.1186/s13195-018-0349-zCitation Count: 30
- Disease progress and response to treatment as predictors of survival, disability, cognitive impairment and depression in Parkinson's disease2012OPENTitle: Disease progress and response to treatment as predictors of survival, disability, cognitive impairment and depression in Parkinson's diseaseJournal Name: British Journal of Clinical PharmacologyPublisher: WileyVol: 74Issue #: 2Start Page: 284End Page: 295Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/j.1365-2125.2012.04208.xCitation Count: 43
- The G2385R risk factor for Parkinson's disease enhances CHIP-dependent intracellular degradation of LRRK22017OPENTitle: The G2385R risk factor for Parkinson's disease enhances CHIP-dependent intracellular degradation of LRRK2Journal Name: Biochemical JournalPublisher: Portland Press Ltd.Vol: 474Issue #: 9Start Page: 1547End Page: 1558Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1042/bcj20160909Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6178381Citation Count: 34
-
OPENTitle: CNTRICS Imaging Biomarkers Final Task Selection: Long-Term Memory and Reinforcement LearningJournal Name: Schizophrenia BulletinPublisher: Oxford University Press (OUP)Vol: 38Issue #: 1Start Page: 62End Page: 72Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/schbul/sbr168Best OA location URL: https://academic.oup.com/schizophreniabulletin/article-pdf/38/1/62/5351297/sbr168.pdfCitation Count: 28
-
OPENTitle: Measurement of autophagy flux in the nervous system in vivoJournal Name: Cell Death & DiseasePublisher: Springer Science and Business Media LLCVol: 4Issue #: 11Start Page: e917End Page: e917Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/cddis.2013.421Best OA location URL: https://www.nature.com/articles/cddis2013421.pdfCitation Count: 111